Editorial: monitoring vedolizumab trough serum concentration in inflammatory bowel disease-following the fate of anti-TNF-alpha agents?
- PMID: 29644739
- DOI: 10.1111/apt.14588
Editorial: monitoring vedolizumab trough serum concentration in inflammatory bowel disease-following the fate of anti-TNF-alpha agents?
Comment on
-
Early vedolizumab trough levels predict mucosal healing in inflammatory bowel disease: a multicentre prospective observational study.Aliment Pharmacol Ther. 2018 Apr;47(7):906-912. doi: 10.1111/apt.14548. Epub 2018 Jan 31. Aliment Pharmacol Ther. 2018. PMID: 29384209
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources